<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Forty female patients with either primary anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (n = 26) or <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome positive) (n = 14) were investigated for levels of factor XII, the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and antibodies to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I and factor XII </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-one patients had a history of recurrent fetal loss (&gt; 2, mean = 2.6) </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> positivity showed a weak association with recurrent fetal loss (odds ratio = 1.1) </plain></SENT>
<SENT sid="3" pm="."><plain>While there was no association between the presence of antibodies to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> or beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I with recurrent fetal loss, antibodies to factor XII showed a strong and statistically significant association (odds ratio = 5.4, P = 0.025) </plain></SENT>
</text></document>